# Oramed Pharmaceuticals

Type: Company (ORMP)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/oramed-pharmaceuticals
Canonical HTML page: https://gethealthbrief.com/entity/oramed-pharmaceuticals

## Timeline

- **2026-03-18**: Financial Reporting — Lifeward scheduled to report Q4 and full-year 2025 financial results.
- **2026-03-13**: Shareholder Approval — Lifeward shareholders vote in favor of the strategic partnership with Oramed.
- **2026-03-11**: Nasdaq Compliance — Lifeward regains compliance with Nasdaq minimum bid price requirements.

## Recent coverage (1 stories)

### Lifeward and Oramed Secure Shareholder Approval for Strategic Biomedical Merger
2026-03-13 13:13:21 · Sentiment: Positive · Impact: 6/10 · Sources: 2

Lifeward Ltd shareholders have officially approved a strategic partnership with Oramed Pharmaceuticals, signaling a major pivot toward becoming a diversified biomedical company. The deal integrates Lifeward's robotic rehabilitation technology with Oramed's pharmaceutical expertise to create a multi-disciplinary healthcare entity.
Full story: https://gethealthbrief.com/story/lifeward-oramed-strategic-biomedical-partnership-approval

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.